scispace - formally typeset
K

Khalid Amin

Researcher at University of Minnesota

Publications -  102
Citations -  1948

Khalid Amin is an academic researcher from University of Minnesota. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 17, co-authored 86 publications receiving 1750 citations. Previous affiliations of Khalid Amin include SRI International & University of Kansas.

Papers
More filters
Journal ArticleDOI

5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.

TL;DR: Evidence that AMPK is activated in authentic hypoxic tumor microenvironments is obtained and that this activity overlaps with regions of hypoxia detected by a chemical probe, which implies that HIF-1 and AMPK are components of a concerted cellular response to maintain energy homeostasis in low-oxygen or ischemic-tissue microen environments.
Journal ArticleDOI

Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury.

TL;DR: Experiments revealed that the rapid cardioprotective effect of EPO during ischemia‐reperfusion injury was associated with preservation of ATP levels in the ischemic myocardium.
Journal ArticleDOI

A novel role for erythropoietin during fibrin-induced wound-healing response.

TL;DR: A novel function for EPO is demonstrated by providing in vivo evidence for a physiological role during fibrin-induced wound healing and correlated with changes in levels of inducible nitric oxide synthase protein in granulation tissue.
Journal ArticleDOI

Functional Significance of Erythropoietin Receptor Expression in Breast Cancer

TL;DR: Local, one-time administration of a neutralizing anti-EPO antibody, soluble EPO receptor, or an inhibitor of Jak2 resulted in a delay in tumor growth with 45% reduction in maximal tumor depth in tumor Z-chamber model in a dose-dependent manner.
Journal ArticleDOI

Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling.

TL;DR: A novel class of indole analogs were used to optimize I3C's anticancer actions, including blocking growth factor-stimulated Akt activation and exhibited potent oral anticancer activity against various cancers and no significant toxicity.